Feedback/ Help/ Queries

Email:
Message:
CaptchaRF
Processing...

Login

CaptchaRF
Forgot password?Create Username

Subscribe now!

United States of America proposed classification of the Device to Detect and Identify Microbial Pathogen Nucleic Acids in Cerebrospinal Fluid

 Alerts

United States of America proposed classification of the Device to Detect and Identify Microbial Pathogen Nucleic Acids in Cerebrospinal Fluid

The Food and Drug Administration (FDA) is classifying the device to detect and identify microbial pathogen nucleic acids in cerebrospinal fluid into class II (special controls). The special controls that will apply to the device type are identified in this order and will be part of the codified language for the device to detect and identify microbial pathogen nucleic acids in cerebrospinal fluid's classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.

Product covered: Medical device to detect and identify microbial pathogen nucleic acids in cerebrospinal fluid

HS code: 9018

Proposed date of adoption: 20-10-2017

Proposed date of entry into force: 20-10-2017

Final date for comments: NA

If the Proposal/Notification/Regulation will affect your International Business please send us your representation with facts and figures , so that these can be taken up suitably.

 


For Exporter
Frequently Asked Questions
Search ITC-HS Code & Tariff
HS Code
 (Please type 2 to 6 digits only)
 OR
Product
         
Upcoming Events
Latest News